Tag: benefit risk assessment
-
After Approval: Running Safety, Real World Evidence, and the Product Lifecycle
This is part 7 and the last part of The Drug Development Playbook. Post‑approval is less about molecules and more about systems, signals, and evidence strategy.
-
From Pivotal Data to Approval: The Regulatory Review Strategy
This is Part 6 of The Drug Development Playbook. This article explains how to turn that data and your manufacturing story into an approval.
Aryan Kenia 